GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (FRA:51B) » Definitions » Price-to-Funds-From-Operations

Bioventix (FRA:51B) Price-to-Funds-From-Operations : (As of Dec. 11, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Bioventix Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Bioventix Business Description

Industry
Traded in Other Exchanges
Address
27–28 Eastcastle Street, London, GBR, W1W 8DH
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.